US vs China: Goodwin Attorneys Discuss Patent Hurdles and Adalimumab Marketing

Huiya Wu, JD, and Freddy Yip, PhD, PCLL, attorneys at Goodwin Procter, discussed biologic drug patent laws in China and the US.